|
FY2016
12 months to Jan 31, 2016
|
FY2015
12 months to Jan 31, 2015
|
FY2014
12 months to Jan 31, 2014
|
|
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Depreciation and amortization | |||
| Loss on disposal of equipment | |||
| Accretion of debt issuance costs to interest expense | |||
| Gain on sale of PCIe product line | |||
| Provision for excess and obsolete inventory | |||
| Allowance for doubtful accounts | |||
| Loss on extinguishment of debt | |||
| PCIe card inventory provision | |||
| Impairment (gain on sale) of cost method investment | |||
| Stock-based compensation | |||
| Changes in operating assets and liabilities, net: | |||
| Accounts receivable | |||
| Inventory | |||
| Other assets | |||
| Accounts payable | |||
| Accrued liabilities | |||
| Deferred revenue | |||
| Net cash used in operating activities | |||
| Cash flows from investing activities: | |||
| Purchase of property and equipment | |||
| Purchase of cost method investments | |||
| Proceeds from sale of PCIe product line | |||
| Proceeds from sale of cost method investment | |||
| Increase in restricted cash | |||
| Purchase of short-term investments | |||
| Proceeds from sale of short-term investments | |||
| Proceeds from maturity of short-term investments | |||
| Net cash provided by (used in) investing activities | |||
| Cash flows from financing activities: | |||
| Proceeds from issuance of convertible notes, net of issuance costs | |||
| Proceeds from issuance of convertible preferred stock, net of issuance costs | |||
| Proceeds from debt and line of credit, net of issuance costs | |||
| Repayment of debt and line of credit | |||
| Proceeds from initial public offering, net of issuance costs | |||
| Proceeds from issuance of common stock, net of related costs | |||
| Proceeds from exercise of common stock options and stock purchase plan | |||
| Repurchase of unvested portion of common stock | |||
| Taxes paid related to net share settlement of equity awards | |||
| Net cash provided by financing activities | |||
| Effect of exchange rates on cash and cash equivalents | |||
| Net increase (decrease) in cash and cash equivalents | |||
| Cash and cash equivalents at beginning of year | |||
| Cash and cash equivalents at end of year | |||
| Supplemental disclosure of other cash flow information: | |||
| Taxes paid | |||
| Interest paid | |||
| Supplemental disclosure of non-cash investing and financing activities: | |||
| Conversion of convertible notes to common stock | |||
| Conversion of convertible preferred stock to common stock | |||
| Conversion of warrant to purchase convertible preferred stock to common stock | |||
| Transfer of inventory to property and equipment | |||
| Conversion of notes payable and accrued interest to convertible preferred stock | |||
| Issuance of Series B convertible preferred stock in exchange for note receivable | |||
| Settlement of loan receivable from officer in lieu of bonus payment | |||
| Issuance of Series D convertible preferred stock in connection with litigation | |||
| Vesting of early stock option exercises | |||
| Payables related to purchases of long-term assets | |||
| Issuance of common stock in settlement of liabilities |
Loading...